Gilead recently reported additional data on remdesivir, an investigational antiviral for the treatment of COVID-19.
For more coronavirus updates, visit our resource page, updated twice...
HHS and the Department of Defense (DoD) recently announced a $1.6 billion agreement with Novavax Inc. to demonstrate commercial-sale manufacturing of the company’s COVID-19 investigational...
In states that switched to drug reimbursement models where results were based on a survey of pharmacy invoices, researchers found no effect on overall Medicaid outpatient drug spending, according to a...
Sanofi and Regeneron Pharmaceuticals recently announced that the US Phase 3 COVID-19 clinical trial of Kevzara in patients requiring mechanical ventilation did not meet its primary and key secondary...
Pfizer and BioNTech recently announced positive preliminary data from an ongoing Phase 1/2 study of the most advanced COVID-19 vaccine candidate in their BNT162 mRNA-based vaccine program.
For more...
FDA is teaming up with the Critical Path Institute and National Center for Advancing Translational Sciences (NCATS) to launch the CURE Drug Repurposing Collaboratory (CDRC) to evaluate existing drugs...
Eli Lilly and Company recently announced that the first patient has been enrolled in a Phase 3 clinical trial to evaluate the efficacy and safety of baricitinib in hospitalized patients with...
Roche recently announced positive phase 3 results from a study evaluating Venclexta (venetoclax) in individuals with untreated acute myeloid leukemia (AML) who were ineligible for intensive induction...
AstraZeneca recently announced that its drug, Calquence (acalabrutinib), showed long-term efficacy and tolerability for patients with chronic lymphocytic leukemia (CLL) in two clinical...
Preliminary data from a clinical trial found that a commonly used steroid – dexamethasone – improves survival in hospitalized COVID-19 patients, according to a press release from Oxford...
Sanofi recently announced that when Sarclisa (isatuximab), a monoclonal antibody, is added to carfilozomib and dexamethasone, it reduces the risk of relapsed multiple myeloma progression or death in...
Eli Lilly and Company recently announced that patients have been dosed in the world’s first study of potential COVID-19 antibody treatments.
For more coronavirus updates, visit...
Gilead Sciences recently announced positive results from its Phase 3 SIMPLE clinical trial evaluating remdesivir as a COVID-19 drug for moderately ill COVID-19 patients.
For more coronavirus updates,...
Bristol Myers Squibb recently announced that Zeposia (ozanimod) 0.92 mg for the treatment of relapsing multiple sclerosis (MS) is now commercially available in the US.
Ozanimod, developed by...
A recent analysis of a randomized clinical trial found that the antidepressant bupropion was not superior to a placebo for the treatment of apathy in patients with dementia of Alzheimer type (DAT)...
GSK recently announced it will manufacture one billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of various adjuvanted COVID-19 vaccine candidates.
For more...
Bristol Myer’s Squibb drug, nivolumab, did not improve overall survival compared with the drug bevacizumab in the treatment of recurrent glioblastoma in a phase 3 clinical trial, according to a...
Women who obtained direct contraceptive prescriptions from their pharmacist were able to minimize breaks in contraceptive coverage, while increasing their continuous adherence, according to researchers...
Merck and IAVI recently announced a joint partnership that will explore the development of an investigational vaccine candidate against SARS-CoV-2 to prevent COVID-19.
For more coronavirus updates,...
HHS recently announced that it will expand pharmaceutical manufacturing in the US to produce medicines needed during the COVID-19 pandemic and boost capacity for producing finished generic drugs.
For...
